Trials / Unknown
UnknownNCT05234658
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery
Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 21 (estimated)
- Sponsor
- Andalusian Network for Design and Translation of Advanced Therapies · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Phase II Clinical Trial Evaluating the Safety and Efficacy of a Tissue Engineered Autologous Skin Substitute Reconstructive Surgery for Basal Cell Carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | PHITAH | Tissue Engineered Human Artificial Skin: Fibrin-Hyaluronic Acid |
| BIOLOGICAL | PHIT | Human artificial skin created by tissue engineering: fibrin-agarose |
| BIOLOGICAL | Skin Autograft | Skin Autograft |
Timeline
- Start date
- 2022-01-21
- Primary completion
- 2024-01-01
- Completion
- 2024-12-01
- First posted
- 2022-02-10
- Last updated
- 2023-11-08
Locations
4 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT05234658. Inclusion in this directory is not an endorsement.